NORTH BILLERICA, Mass.--(BUSINESS WIRE)--May 19, 2016--
Lantheus
Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus
Medical Imaging, Inc. (“LMI”), today announced it will be presenting
at the Jefferies 2016 Healthcare Conference on Tuesday, June 7 in New
York. Mary Anne Heino, President and Chief Executive Officer, and Jack
Crowley, Chief Financial Officer, will present in a session scheduled at
2:00 p.m. Eastern Time.
To access a live webcast of the presentation, please visit the Company’s
website at www.lantheus.com.
A replay of the webcast will be available on the Company’s website for
30 days following the live presentation.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Lantheus
Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc.,
a global leader in the development, distribution and commercialization
of innovative diagnostic imaging agents and products. LMI provides a
broad portfolio of products, which are primarily used for the diagnosis
of cardiovascular diseases. LMI’s key products include the
echocardiography contrast agent DEFINITY® Vial for
(Perflutren Lipid Microsphere) Injectable Suspension; TechneLite®
(Technetium Tc99m Generator), a technetium-based generator that provides
the essential medical isotope used in nuclear medicine procedures; and
Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent
used to evaluate pulmonary function and for imaging the lungs. The
Company is headquartered in North Billerica, Massachusetts with offices
in Puerto Rico, Canada and Australia. For more information, visit www.lantheus.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160519006121/en/
Source: Lantheus Holdings, Inc.
Lantheus Holdings, Inc.
Meara Murphy, 978-671-8508
